OKYO Pharma Ltd

OKYO · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.1B · 4 employees
148
SEC Filings
$1.7
Close 2026-06-02
4
Employees

Latest Stock Quote

OKYO 2026-06-02 $1.7 O:$1.73 H:$1.76 L:$1.66 Vol:0.1M VWAP:$1.69
origin leaf: 1328b62aa4924b39612ea63bb65535e2a5b71c63e9c72a5d29559f33db3c3592

148 total filings indexed. 148 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001849296
TickerOKYO
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
Websitehttps://www.okyopharma.com
Listed2022-05-17

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 1b1afc22d7adf4944f8de559659b244be45965afc6f7b44e11ec458497a25bec
parent: f6060739f95adbfab69cc476775972c1b881a0533ec5990238562c8a1f262261
content hash: b6c260e7f8b12721ed5cd501f7ac9567e91cbcf36da415435454edaed15e5739
signed: 2026-06-03T12:02:07.669Z
sources: 1 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf